Trimethoprim-sulfamethoxazole treatment for meningitis owing to multidrug-resistant Elizabethkingia meningoseptica in an extremely low-birthweight, premature infant

Gokce, İSMAİL; ONCEL, Mehmet; Ozdemir, RAMAZAN; ERDEVE, Omer; OGUZ, Serife; CANPOLAT, Fuat; URAS, Nurdan; DILMEN, Ugur

doi:10.1179/2046905511y.0000000008

Trimethoprim-sulfamethoxazole treatment for meningitis owing to multidrug-resistant Elizabethkingia meningoseptica in an extremely low-birthweight, premature infant

Atıf İçin Kopyala

Gokce I. K., ONCEL M. Y., Ozdemir R., ERDEVE O., OGUZ S. S., CANPOLAT F. E., ...Daha Fazla

PAEDIATRICS AND INTERNATIONAL CHILD HEALTH, cilt.32, sa.3, ss.177-179, 2012 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 32 Sayı: 3
Basım Tarihi: 2012
Doi Numarası: 10.1179/2046905511y.0000000008
Dergi Adı: PAEDIATRICS AND INTERNATIONAL CHILD HEALTH
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.177-179
İnönü Üniversitesi Adresli: Evet

Özet

Elizabethkingia meningoseptica is a recognised cause of meningitis in premature neonates and severe infections in immunocompromised adults; multi-drug resistance is a major issue. A premature infant developed sepsis, meningitis and hydrocephalus owing to E. meningoseptica and was treated successfully with trimethoprim-sulfamethoxazole (TMP-SMZ) for 3 weeks. A ventriculoperitoneal shunt was required for hydrocephalus. This is the youngest patient with meningitis caused by E. meningoseptica to have responded to TMP-SMZ.